Eden Research (LON:EDEN) Stock Price Down 13.2% – Here’s Why

Posted by Teresa Graham on Apr 2nd, 2025

Eden Research plc (LON:EDEN – Get Free Report)’s stock price was down 13.2% during trading on Monday . The company traded as low as GBX 2.26 ($0.03) and last traded at GBX 2.37 ($0.03). Approximately 1,775,147 shares traded hands during mid-day trading, an increase of 133% from the average daily volume of 762,776 shares. The stock had previously closed at GBX 2.73 ($0.04).

Eden Research Stock Performance

The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The stock’s 50-day moving average price is GBX 3.36 and its 200 day moving average price is GBX 3.71. The company has a market cap of £14.35 million, a P/E ratio of -9.42 and a beta of 0.92.

Insider Buying and Selling

In related news, insider Lykele van der Broek bought 256,000 shares of the company’s stock in a transaction that occurred on Thursday, February 6th. The shares were acquired at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($13,238.53). Also, insider Alexander John Abrey purchased 167,947 shares of Eden Research stock in a transaction on Tuesday, March 4th. The stock was bought at an average cost of GBX 3 ($0.04) per share, with a total value of £5,038.41 ($6,513.78). Insiders have bought 1,391,473 shares of company stock worth $103,604,725 in the last quarter. 14.02% of the stock is currently owned by company insiders.

About Eden Research

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.